Albemarle Reports First Quarter 2026 Results
Albemarle delivered strong Q1 results with net sales rising 33% year-over-year to $1.4 billion and adjusted EBITDA surging 148% to $664 million, driven by higher pricing and volumes in Energy Storage and Specialties. The company improved its 2026 outlook for the Specialties segment, citing higher bromine pricing, while maintaining full-year capital expenditure guidance of $550 million to $600 million.
Key figures
- Eps
- 2.34
- Guidance
- 2026 Specialties net sales $1.3-$1.5B; Specialties Adj EBITDA $225-$275M; Interest expense $120-$140M; CapEx $550-$600M
- Revenue Yoy
- 33%
- Fcf
- 247568000
- Net income
- 319100000
- Debt reduction
- 1300000000
- Adjusted ebitda
- 663800000
- Divestiture proceeds
- 648000000
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.